Yes, a thyroglobulin level of 2.7 ng/mL is possible and concerning six years after total thyroidectomy and RAI ablation.
Your thyroglobulin (Tg) level of 2.7 ng/mL indicates either persistent thyroid tissue or recurrent disease, and you need immediate further evaluation with neck ultrasound and possibly additional imaging.
Why This Level is Abnormal
After total thyroidectomy and RAI ablation, your Tg should be undetectable or extremely low. According to ESMO guidelines, stimulated Tg levels <1 ng/mL are highly predictive of excellent response to therapy 1. Your unstimulated Tg of 2.7 ng/mL—six years post-treatment—suggests:
- Residual thyroid tissue that survived both surgery and RAI, or
- Recurrent/persistent thyroid cancer
Your TSH of 0.877 µIU/mL is appropriately suppressed (though not aggressively), and your T4 of 121 pmol/L indicates adequate thyroid hormone replacement. These values confirm you're on levothyroxine, making your Tg measurement valid for interpretation.
What This Means Clinically
The ESMO guidelines classify your situation as either "indeterminate response" or "biochemical incomplete response" 1. This classification matters because:
- Detectable Tg without structural disease on imaging = indeterminate or biochemical incomplete response
- The positive predictive value increases with higher Tg levels or rising trends over time 1
- Rising Tg is highly suspicious for persistent/recurrent disease 1
Recent research confirms that even low-level Tg elevations predict structural recurrence. A 2025 multicenter study found that Tg ≥0.3 ng/mL optimally predicted structural recurrence, and levels ≥5.0 ng/mL independently predicted elevated recurrence risk 2. Your level of 2.7 ng/mL falls in a concerning middle zone.
Critical Next Steps
You need the following workup immediately:
Check thyroglobulin antibodies (TgAb) - These can interfere with Tg assays and cause false readings 1. If positive, they complicate interpretation but rising TgAb levels themselves can indicate recurrent disease 1.
Neck ultrasound - This is the most effective tool for detecting structural disease and should examine the thyroid bed and cervical lymph nodes 1. Combined with Tg levels, neck US achieves nearly 100% accuracy 1.
Review your Tg trend - Has your Tg been stable, rising, or falling over the past 6 years? A short Tg doubling time (<1 year) is associated with poor outcomes and should prompt immediate imaging 1. Even if your Tg was previously lower and is now rising, this is highly suspicious 2.
Consider stimulated Tg testing - If your unstimulated Tg is 2.7 ng/mL, a stimulated Tg (after rhTSH or thyroid hormone withdrawal) will likely be significantly higher and help clarify your risk 3.
Management Based on Findings
If neck ultrasound shows suspicious findings:
- FNA biopsy of suspicious nodes (Tg washout from FNA fluid can confirm metastases) 1
- Consider cross-sectional imaging (CT/MRI) if deep structures need evaluation 1
- Possible FDG-PET scan if rising Tg trend without clear structural disease 1
If neck ultrasound is negative:
- Repeat imaging every 3-6 months with serial Tg monitoring 1
- Consider whole-body RAI scan or FDG-PET to locate occult disease 1
- Your TSH suppression may need adjustment to <0.1 µIU/mL given biochemical incomplete response 1
Important Caveats
Common pitfall: Assuming all thyroid tissue was eliminated by surgery and RAI. Research shows that even after total thyroidectomy and RAI, Tg levels can take years to reach nadir—but they should trend downward, not remain elevated at 2.7 ng/mL six years later 4. In one study, 25% of patients required >18 months to reach nadir Tg, but 94% eventually achieved Tg <1 ng/mL by 18 months 4.
Your situation is different: At 6 years post-treatment with Tg of 2.7 ng/mL, you're well past the expected timeframe for Tg normalization. This is not residual tissue slowly declining—this represents either persistent disease or inadequate initial treatment.
The answer to your question is yes, this level is possible—but it's abnormal and requires urgent investigation to determine if you have recurrent thyroid cancer that needs treatment.